CIRM awards $2mln in G-Rex Grants to 8 CGT manufacturers.
ByAinvest
Tuesday, Sep 9, 2025 7:09 am ET1min read
TECH--
The G-Rex Grants, ranging from $125,000 to $300,000, were awarded to prestigious institutions including UC San Diego, City of Hope, Stanford Medicine, USC/CHLA, UC Davis, UCSF, UCLA, and Cedars Sinai. These grants are part of ScaleReady's $40 million initiative to advance CGT development and manufacturing [2].
The awardees will receive exclusive support from ScaleReady's consortium of G-Rex Grant Partners, offering expertise in cGMP manufacturing, quality control, regulatory affairs, and CGT business operations. This support will help accelerate the development and commercialization of innovative CGT therapies.
References:
[1] https://www.prnewswire.com/news-releases/scaleready-awards-g-rex-grants-to-support-cell-and-gene-therapy-manufacturing-in-california-302548014.html
[2] https://www.stocktitan.net/news/TECH/scale-ready-awards-g-rex-grants-to-support-cell-and-gene-therapy-qejbcphc9d10.html
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, have awarded eight G-Rex Grants totaling nearly $2 million to awardees of the California Institute for Regenerative Medicine's Manufacturing Network program. The grants aim to enhance operations and establish partnerships with industry and non-profit stakeholders, further establishing California as a world leading hub of cell and gene therapy manufacturing.
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, has awarded eight G-Rex Grants totaling nearly $2 million to awardees of the California Institute for Regenerative Medicine's (CIRM) Manufacturing Network program. The grants aim to enhance operations and establish partnerships with industry and non-profit stakeholders, further establishing California as a world-leading hub of cell and gene therapy (CGT) manufacturing [1].The G-Rex Grants, ranging from $125,000 to $300,000, were awarded to prestigious institutions including UC San Diego, City of Hope, Stanford Medicine, USC/CHLA, UC Davis, UCSF, UCLA, and Cedars Sinai. These grants are part of ScaleReady's $40 million initiative to advance CGT development and manufacturing [2].
The awardees will receive exclusive support from ScaleReady's consortium of G-Rex Grant Partners, offering expertise in cGMP manufacturing, quality control, regulatory affairs, and CGT business operations. This support will help accelerate the development and commercialization of innovative CGT therapies.
References:
[1] https://www.prnewswire.com/news-releases/scaleready-awards-g-rex-grants-to-support-cell-and-gene-therapy-manufacturing-in-california-302548014.html
[2] https://www.stocktitan.net/news/TECH/scale-ready-awards-g-rex-grants-to-support-cell-and-gene-therapy-qejbcphc9d10.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet